https://t.me/auraxchan/297...
A network analysis of COVID-19 mRNA vaccine patents
A preliminary network analysis highlights the complex intellectual property landscape behind mRNA-based COVID-19 vaccines.
The COVID-19 pandemic has had a substantial impact on global health and highlighted the importance of international cooperation to effectively combat SARS-CoV-2. Since the discovery and publication of the virus’s genome in January 2020, scientists have rushed to develop vaccines, therapeutics and diagnostics on an unprecedented timescale. To date there are 80 vaccines in clinical trials and 70 more in clinical development, setting the stage for some of the fastest vaccine development and testing in modern history1. The vaccine technology platforms used by the most promising vaccine candidates range from viral vector–based and protein-based technologies to mRNA and lipid nanoparticle technology.
https://www.nature.com/art...
A network analysis of COVID-19 mRNA vaccine patents
A preliminary network analysis highlights the complex intellectual property landscape behind mRNA-based COVID-19 vaccines.
The COVID-19 pandemic has had a substantial impact on global health and highlighted the importance of international cooperation to effectively combat SARS-CoV-2. Since the discovery and publication of the virus’s genome in January 2020, scientists have rushed to develop vaccines, therapeutics and diagnostics on an unprecedented timescale. To date there are 80 vaccines in clinical trials and 70 more in clinical development, setting the stage for some of the fastest vaccine development and testing in modern history1. The vaccine technology platforms used by the most promising vaccine candidates range from viral vector–based and protein-based technologies to mRNA and lipid nanoparticle technology.
https://www.nature.com/art...
04:01 PM - Oct 19, 2021
Only people mentioned by Duende in this post can reply
